Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lowell B Anthony

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2011
Radioguided exploration facilitates surgical cytoreduction of neuroendocrine tumorsYi-Zarn Wang, Anne Diebold, Eugene Woltering, et al.
Seminars in Nuclear Medicine|April 20, 2002
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignanciesLowell B Anthony, Eugene A Woltering, Gregory D Espenan, et al.
The American Surgeon|January 26, 2012
A prospective evaluation of the value of intensive previsit counseling in patients with neuroendocrine tumorsJarret Brashear, Pamela Ryan, Yi-Zarn Wang, et al.
Oncotarget|May 4, 2018
Global burden of neuroendocrine tumors and changing incidence in KentuckyAman Chauhan, Qian Yu, Neha Ray, et al.
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Neuroendocrinology|April 1, 2015
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 TrialLowell B Anthony, Marianne E Pavel, John D Hainsworth, et al.
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Neuroendocrine tumors: current recommendations for diagnosis and surgical managementSaju Joseph, Yi-Zarn Wang, J Philip Boudreaux, et al.
Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectumLowell B Anthony, Jonathan R Strosberg, David S Klimstra, et al.
Journal of Surgical Oncology|May 31, 2016
Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysisHayder Saeed, Dima Hnoosh, Bin Huang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2011
Radioguided exploration facilitates surgical cytoreduction of neuroendocrine tumorsYi-Zarn Wang, Anne Diebold, Eugene Woltering, et al.
Seminars in Nuclear Medicine|April 20, 2002
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignanciesLowell B Anthony, Eugene A Woltering, Gregory D Espenan, et al.
The American Surgeon|January 26, 2012
A prospective evaluation of the value of intensive previsit counseling in patients with neuroendocrine tumorsJarret Brashear, Pamela Ryan, Yi-Zarn Wang, et al.
Oncotarget|May 4, 2018
Global burden of neuroendocrine tumors and changing incidence in KentuckyAman Chauhan, Qian Yu, Neha Ray, et al.
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Neuroendocrinology|April 1, 2015
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 TrialLowell B Anthony, Marianne E Pavel, John D Hainsworth, et al.
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Neuroendocrine tumors: current recommendations for diagnosis and surgical managementSaju Joseph, Yi-Zarn Wang, J Philip Boudreaux, et al.
Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectumLowell B Anthony, Jonathan R Strosberg, David S Klimstra, et al.
Journal of Surgical Oncology|May 31, 2016
Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysisHayder Saeed, Dima Hnoosh, Bin Huang, et al.
Pageof 4